Fact CheckerSign in

NCT05357768Recruiting

Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project

Source: ClinicalTrials.gov · Last updated 30 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Experimental study with biological material : case series review of clinical and histological data

Status (registry)
Recruiting
Study type
Observational
Enrollment
260 (estimated)
First submitted
27 Apr 2022
Start date
11 Jun 2019
Primary completion date
31 Dec 2026
Lead sponsor
Istituto Ortopedico Rizzoli
Diseases
Sarcoma
NCT number
NCT05357768

What you commit to

  • Study type: Observational
  • Planned participants: 260
  • From 11 Jun 2019 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Diagnosis different from undifferentiated round cell sarcomas
  • Patient with no clinical or outcome information available

Who the study is looking for

  • Patients with undifferentiated round cell sarcomas treated from 01 January 1983 and all new patients will be included.
  • Clinical and outcome information available.
  • Histological slides/formalin-fixed paraffin-embedded tissue tumor blocks from archive available to perform the histology analysis/frozen tissue representative of the tumor available.

Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Istituto ortopedico Rizzoli
Coordinator of this site? Confirm its status
BolognaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.